COVID-19 demonstrates the value of open access: What happens next?

Willa Tavernier


In the wake of COVID-19, many publishers have tacitly agreed that open access is beneficial to scientific advancement and necessary to move science forward to combat disease. Publishers have committed to open access publication of scientific articles relating to the disease. Some are facilitating rapid and open peer review and fast-tracking the publishing of related research. Pulitzer Prize-winning journalist Michael Hiltzig refers to this convincing demonstration of the value of open access to scientific research as one of the most important positive disruptions caused by COVID-19.

Full Text:

Copyright Willa Tavernier

Article Views (Last 12 Months)

No data available

Contact ACRL for article usage statistics from 2010-April 2017.

Article Views (By Year/Month)

January: 112
February: 104
March: 122
April: 69
May: 98
June: 29
January: 119
February: 93
March: 100
April: 111
May: 131
June: 105
July: 105
August: 123
September: 133
October: 315
November: 379
December: 221
January: 0
February: 0
March: 0
April: 13
May: 1154
June: 488
July: 221
August: 123
September: 87
October: 356
November: 184
December: 70